Thirteen people were arrested following raids at four drug manufacturing units in the Indian states of Gujarat and Rajasthan, resulting in the seizure of
mephedrone valued at Rs 230 crore (approximately 22.30 million GBP), according to a news agency report.
The Gujarat Anti-Terrorist Squad (ATS) and Narcotics Control Bureau conducted the raids jointly on Friday, prompted by a tip-off received by the ATS indicating
that Ahmedabad resident Manoharlal Enani and Kuldeepsinh Rajpurohit from Rajasthan had set up mephedrone manufacturing units, PTI reported on Saturday, quoting
an official.
As stated in an ATS release obtained by the news agency, the raids were conducted at the units in Sirohi and Jodhpur in Rajasthan and Piplaj village in Gandhinagar
and Bhaktinagar industrial area of Amreli district in Gujarat.
"The ATS recovered 22.028 kilograms of mephedrone (in solid form) and 124 kilograms of liquid mephedrone, collectively valued at Rs 230 crore(approximately
22.30 million GBP).
"Rajpurohit was nabbed during the raid in Gandhinagar and Enani was held from Sirohi," it said.
Boots UK to offer a free health MOT for over 40s in England between 1st April until 30th June to help eligible patients identify and take the right steps to
address high blood pressure and the potential for increased risk of other health conditions.
The Free Health MOT will give over 40s the information needed for them to take actions to support their overall health. It consists of a 15-minute appointment with
a Boots pharmacist, during which they will receive- the NHS Blood Pressure Check Service, with GP referral if needed; optional BMI (Body Mass Index) and waist
circumference measurement; lifestyle guidance on exercise, nutrition, sleep, mental wellbeing and stopping smoking; and personalised advice and recommendations .
At the end of their appointment, patients will receive a booklet containing information about how to lead a healthy lifestyle and a section with the results of their
MOT recorded.
Claire Nevinson, Superintendent Pharmacist at Boots, said: "The Free Health MOT at Boots is intended to help people gain greater insight into their health and take
the steps they need to improve it. As we get older, we become more vulnerable to conditions like high blood pressure, so it's important that we take steps to help
stay healthy. The checks done during the MOT and the advice provided not only helps individual patients lead healthier lives but also reduces pressure on the NHS by
offering accessible care in pharmacies at the heart of communities."
The availability of appointments for a Free Health MOT at Boots comes at a time when new research indicates people want to lead healthier lives.
Drug testing is a crucial part of many people's lives. Whether you're applying for a job in the law enforcement field, military, or pharmacy industry, it can
be difficult to find out what drugs are on your application. Luckily, there are new ways to test yourself at home to see if you have any traces of drugs inside of
you.
WHERE TO FIND DRUG TESTS
There are a variety of at-home drug tests available on the market. Drug tests can be found at most pharmacies and online retailers, like Drug Test City. Some of
these sites are free, while others charge a fee. Here are some tips to help you choose the right site for your needs:
Make sure the site is reputable. There are many scam sites out there that will take your money and not deliver on their promises. Do some research to make sure the
site you're considering is legitimate.
Consider the cost. Some sites charge a fee for their services, while others are free. Decide what you're willing to spend before you start your search.
Compare features. Not all drug testing sites are created equal. Some offer more comprehensive services than others. Take a look at what each site has to offer and
choose the one that best meets your needs.
The Pharmacists' Defence Association (PDA) has reacted to the chief pharmaceutical officer (CPhO) for Wales's offer for community pharmacy contractors,
offering a funding uplift for community pharmacy on the condition of an increase in pay for some staff by at least the amount currently being imposed upon NHS
employees.
The PDA has expressed a mixed reaction to the intervention being attempted by the Welsh government.
"It is unusual for a government to be so closely involved in the pay of their suppliers' employees and those at some community pharmacy employers have a contractual
right to a pay review at times of year that may not synchronize with the government's financial cycle, so this initiative may have different impacts at different
employers," said the association.
"In addition, the PDA negotiates pay at the largest two community pharmacy employers and works alongside other trade unions that organise other pharmacy workers.
This government intervention must not disrupt or attempt to bypass those processes."
His Royal Highness the Prince of Wales is to host a reception at St James's Palace in early May to celebrate exemplary work of community pharmacist during
the Coronavirus pandemic.
Up to 200 community pharmacists have been invited by Prince Charles to the event organised to "celebrate community pharmacists", which commences at 5:30pm on
Wednesday, May 4 at the London residence of the Prince of Wales.
The invitation comes in less than six months after Prince Charles praised community pharmacists for their efforts during the Covid-19 pandemic in a video message sent to the National Pharmacy Association (NPA)'s centenary dinner at Apothecaries' Hall in central London in November last year.
He said throughout the pandemic pharmacy teams' "commitment to patient care has never wavered, despite the many enormous pressures you have faced.
"During this pandemic period, we have learned, as never before, that pharmacies are one of those vital places where science and society meet. Crucially, they are about people and places, not just pills."
Professional leadership bodies from around the world discussed workforce shortages in community pharmacy and other challenges affecting the sector at a global
meeting held in Paris last month.
Delegated from Denmark, Australia, Ireland, New Zealand, Portugal, Spain, US and the UK updated the conference on how the profession was progressing in practice,
technology and workforce development in their respective countries.
The UK was represented at World Pharmacy Council meeting by National Pharmacy Association chair Andrew Lane and chief executive at the Pharmaceutical Services
Negotiating Committee Janet Morrison.
Lane said: "It's very useful to be part of a global network of pharmacy bodies who are all going through similar challenges as we are in the UK. Sharing intelligence
on other pharmacy systems around the world helps us to prepare the right strategy for engaging with the NHS at home.
"Hearing some of the strides in services and digital technology in the profession gives us hope for the future of the sector. It's clear however that key challenges
such as workforce shortages are starting to have an effect in other parts of the world too."
Pharma giant, Pfizer has announced plans to cut 500 jobs at its Sandwich site in Kent, England as part of its ongoing $3.5 billion cost-cutting drive.
The company is also planning to shut its Pharmaceutical Sciences Small Molecule (PSSM) capabilities at the site, a spokesperson of the company told FiercePharma.
However, the Sandwich site will remain open and other functions will continue with "a different size," the spokesperson added.
Currently, around 940 people are employed at the site, which is the location where Pfizer scientists first discovered Viagra.
"We are proud of our heritage of breakthrough science in the UK and we will retain a scientific presence in the U.K. including at our Discovery Park location
in Sandwich," Pfizer's spokesperson confirmed in an email to FiercePharma.
Nestled in the heart of a bustling high street and a housing estate, at Lincoln Pharmacy, part of Mildcare Ltd Group, in Tower Hamlets in London, the scene
is a testament to resilience and innovation, where queues of people seek aid from a pharmacy technician stationed behind a glass window-a symbol of the enduring
impact of the pandemic.
Amidst the array of modern amenities at the pharmacy stands Atulkumar Patel, the proprietor and Independent Prescriber (IP) at Lincoln Pharmacy, whose vision has
propelled the establishment into a beacon of progressive healthcare.
Owner of two Pharmacies, Patel's team of 20 dispenses an average of 20,000 prescriptions monthly, maintaining an NHS/OTC split of 80/20.
Recipient of the prestigious Independent Prescriber of the Year award at the Pharmacy Business Awards 2023, Patel reflects on the pivotal moment when his
pharmacy pioneered the rollout of COVID-19 vaccine jabs within the community.
"When doctors' doors closed, pharmacy was the only place where people could get help and care," Patel recounts, emphasising the pivotal role pharmacies played
during the crisis.
Patel's dedication during the pandemic extended beyond mere service provision; it was about showcasing the untapped potential of pharmacies.
The Pharmacists' Defence Association (PDA) has expressed concerns over Boots UK's decision to reduce supplemental opening hours at some pharmacies.
The association stated: "Some pharmacists and other staff at Boots are being notified this week of changes to opening hours at their place of work, with local briefings taking place. The PDA are supporting their members to deal with any potential impact on their employment."
It said that reducing pharmacy opening hours would affect patients' access to a trusted healthcare professional, especially if it is being done by the largest community pharmacy multiple.
It even called upon the NHS to adequately fund community pharmacies to ensure they remain open when patients and local communities need their services.
Meanwhile, Boots management has informed PDA that most of its employees are not pharmacists, and "less pharmacists are expected to be directly impacted by these changes than other colleagues," PDA said.
Later this week I will be speaking at the Pharmacy Business Diversity Conference on a panel exploring LGBTQ+ inclusion in the workplace.
I came out as a gay man at 15 and have been out (openly gay) at work ever since. I've never knowingly suffered homophobia at work, and I know how lucky that makes me.
Too many LGBTQ+ people's experience of work is not as positive as mine.
Addressing microaggressions
When reflecting for the upcoming panel, I realised that, even for people who were not subjected to some of the awful examples I've heard about, working life can be exhausting.
Although microaggressions can seem trivial to those not on the receiving end, they create a culture where people feel the need to hide who they are and make work unwelcoming.
Most people can understand that shouting homophobic language across an office is wrong. Talking about microaggressions seems to be much more challenging, which is why addressing them in a workplace requires conscious and positive action.
The Pharmacists' Defence Association (PDA) is playing a vital role in helping pharmacists who are dealing with stress at the workplace. It launched its new
awareness factsheet 'It's Time to Address Stress' last week.
The factsheet looks at the causes and symptoms of stress in the workplace and provides advice on ways pharmacists can access support and improve working conditions.
The association said that it recognises the well-being services offered by employers and specialist charities such as the PDA's charity partner Pharmacist Support
play an important part in helping pharmacists who may be experiencing stress.
However, the PDA is also committed to working with members to challenge employers to provide well workplaces and to help them to make real impact changes. This can
be done by addressing the causes of stress and fulfilling their responsibilities to their employees.
It added: "Under the management of Health and Safety at Work Regulations 1999, employers are required by law to protect employees from harm. Their legal obligations include identifying hazards and risks and implementing ways to reduce or eliminate them. The PDA's new factsheet highlights the importance of employers recognising the hazards causing stress as the health and safety issues they are."
The National Pharmacy Association (NPA) has appointed Paul Rees MBE as its new Chief Executive, with his role commencing on November 27th. Rees, currently
serving as the Chief Executive of the Royal College of Psychiatrists and having held various roles throughout his career, will succeed Mark Lyonette, who is
retiring, NPA said in a statement.
"We anticipate Paul joining the NPA after a thorough recruitment process affirmed his suitability," said Nick Kaye, Chair of NPA. "Throughout his career, including
his role at the Royal College of Psychiatrists, he has made a significant impact and achieved concrete changes in healthcare and society. I would also like to
express my appreciation to Mark for his work as Chief Executive since 2018. He still has important tasks to complete at the NPA before his retirement."
Rees has also held key positions at prominent organisations, including the Ramblers Association, National Housing Federation, Charities Aid Foundation, Association
of University Teachers, and the , besides being the Head of Communications at the Home Office.
Amgen's experimental obesity drug demonstrated promising durability trends in an early trial, paving the way for a larger mid-stage study early next year,
company officials said ahead of a data presentation on Saturday (December 3).
The small Phase I trial found that patients maintained their weight loss for 70 days after receiving the highest tested dose of the injected drug, currently known as
AMG133.
Amgen shares have gained about 5% since the company said on Nov. 7 that 12 weeks of trial treatment at the highest monthly dose of AMG133 resulted in mean weight
loss of 14.5%.
At 150 days after the last dose, maintained weight loss had dropped to 11.2% below original weight at the start of the trial, according to findings detailed at a
meeting of World Congress of Insulin Resistance, Diabetes and Cardiovascular Disease in Los Angeles.
Patients treated with AMG133 did have side effects including nausea and vomiting, but most cases were mild and resolved within a couple of days after the first dose,
Amgen said.
Global consumer healthcare company Haleon has launched a new centre of excellence for a global leader in consumer health which will bring together world leading
academics in human behaviour and frontline healthcare professionals including community pharmacists.
Unveiled at the International Pharmaceutical Federation (FIP) Congress in 'sunny' Seville, Spain on September 20, the Centre will operate as a community of healthcare
professionals and specialists in behavioural science, health psychology and the social sciences to solve some of the most pressing everyday health challenges.
Named the Centre for Human Sciences (CHS) the initiative will be the first major programme for healthcare professionals since the Haleon's launch on July 18 as an
independent, global leader in consumer health.
The Centre's mission is to support practising health professionals - pharmacists, pharmacy assistants and dental professionals - in serving their patients and
communities. Combining science with deep human understanding, CHS will bring expertise in physiology together with human sciences to deliver real world-solutions
and tangible interventions, resulting in measurable improvements in health outcomes through sustained behavioural change.
The Centre is facilitated by Robert Horne, professor of Behavioural Medicine at UCL School of Pharmacy, who started his career as a practising pharmacist but later
chose to become a behavioural scientist when he saw an opportunity to address issues around psycho-social factors that acted as a hindrance in pharmacy practice.
Speaking to me in an exclusive three-way conversation alongside Tess Player, the global head of healthcare professional & health influencer marketing at Haleon, on
the sidelines of the FIP Congress 2022, Prof Horne expanded on what the Centre was all about and how it would work.
"We've got some good ideas, but it's not a pre-filled prescription that we're going to deliver at scale from the start. What Haleon is t
In his maiden speech delivered to community pharmacy since becoming new minister with responsibility for the sector, Will Quince MP said he's determined to be
"your champion" and "voice in government".
Addressing delegates on Wednesday (Oct 12) as chief guest at the 22nd Pharmacy Business Awards in central London, he praised community pharmacy for delivering 25
million Covid-19 vaccines, five million flu jabs, 200 million lateral flow testing kits and millions of medicines throughout the pandemic.
"These local efforts became the national success story," he told over 600 attendees at a gala dinner held at the iconic Park Plaza Westminster Bridge hotel
overlooking the Houses of Parliament.
'We need you now'
Quince, who was appointed minister of state at the Department of Health and Social Care on 7 September 2022, added: "Just as we needed you in the pandemic, we
need you now," highlighting the vital role of community pharmacy in realising the secretary of state (Thérèse Coffey)'s vision, particularly in regard to her
much talked about 'Plan for Patients'.
The Department of Health and Social Care (DHSC) has confirmed on Thursday (15 June) that everyone aged 60 and over will continue to receive free prescriptions.
In response to a consultation launched by the DHSC in 2021 looking at whether the age free prescriptions become available should be aligned with the State Pension
age, which is currently 66, the government decided to freeze the age at 60.
Minister for Health Neil O'Brien said: "This government recognises the pressures with the cost of living caused by Russia's invasion of Ukraine. That's why we are
providing cost of living help worth £3,300 on average per household over last year and this, among the most generous help anywhere in Europe.
"It's also why we have decided to maintain the prescription exemption age where it is. Nine out of 10 prescriptions are already free at the point of use and on top
of that we also provide financial help to others on low incomes who don't automatically get prescriptions for free.
"Prescription charge exemptions will also remain in place for those aged under 16 or aged 17 and 18 but in full time education, while those in receipt of certain
benefits can also receive free prescriptions," said DHSC.
For those who do not qualify for an exemption or the NHS Low Income Scheme, prepayment certificates (PPC) are available to help with frequent prescriptions should
they be required.
The annual PPC can be paid for through 10 instalments. This means people can have as many prescription items as needed for just over £2 per week.
Professor Harry McQuillan has said community pharmacists in the UK must change their focus from an 'accuracy of supply' to a 'safety of supply' model when it
comes to dealing with patients.
"The main take away message from tonight's lecture is for pharmacy professionals to really challenge themselves about whether they are focused on accuracy of supply
or safety of supply," he said at this year's UCL School of Pharmacy Lecture in London on Thursday, 15 June.
"For our community pharmacists it must be about safety, including prescribing, and ensuring patients and citizens get the maximum benefit from prescribed medicines.
"To deliver this, we need to invest in our teams - harness technology and always be willing to take the next step in a more clinical future."
The Chief Executive Office of Community Pharmacy Scotland, however, noted that at a time when the UK was grappling with an unprecedented national debt crisis
exacerbated by severe cost of living and spiraling inflation, community pharmacy will need to make a "compelling case" of where the priority should be in the sector.
Expanding on the financial woes of the country, he compared the current national debt of the UK, which stood at a staggering 270 percent of GDP in September 2022,
with the previous record-breaking national debt of 250 per cent at the end of WWII.
The NHS has made major improvements across long waits, urgent and emergency services, and cancer care, latest performance figures published on Thursday (11)
have shown.
The number of patients waiting more than 18 months fell to 10,737 by April - down by more than 90 per cent from 124,911 in September 2021 and by more than four-fifths
since the start of January when there were 54,882.
Around half of NHS trusts in England have no patients on their elective care waiting lists apart from those who have chosen to wait longer. More than one in
five (21%) trusts had completely eliminated 18-month waits.
However, the overall waiting list has risen to over 7.3 million entries in England.
"I promised I would cut NHS waiting lists and we are delivering," Prime Minister Rishi Sunak said. "Reducing 18-month waits by over 90 per cent is huge progress,
and it is testament to the hard work of NHS staff who have achieved this despite one of the busiest winters on record.
"We still have work to do, but backed by record government investment and the ongoing efforts of the NHS, I am confident we will get patients the care they need
more quickly."
Ambulance response rates have improved to their fastest in two years, with average category two response times now at 28.5 minutes and category one at 8 mins.
The 62-day cancer backlog has fallen for the first time since before the pandemic, with those waiting two months or more down from 21,823 at the end of the last
financial year (March 2022) to 19,248 at the end of this March (2023). This is down almost 15,000 from a peak of 34,000 in July 2022.
The Royal Pharmaceutical Society (RPS) has appointed Neville Carter as its new chief education and membership officer.
Neville joins RPS from the Royal Society of Medicine (RSM) where he is currently director of engagement, leading a team of over 60 and responsible for creating a
combined directorate accountable for education, membership, philanthropy, and business development.
He has, in particular, led on the development of a digital education strategy and launched professional development training programmes for members.
Prior to joining the RSM, Neville worked as director of product and sales at the British Medical Association with responsibility for membership growth, supporting
corporate transformation and developing and managing member benefits and relationships with third-party providers to support revenue growth. He also has senior
manager experience at the RAC and at British Airways.
Commenting on the appointment, Paul Bennett, RPS CEO, said: "I'm delighted that Neville will be joining our Executive team. He brings a wealth of relevant experience
and this, in combination with a strong existing education and membership team at RPS and a clear ambition to strengthen the relevant functions further, will enable
the organisation to deliver a dynamic offering for our members.